Literature DB >> 1287419

In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice.

I B Autenrieth1, J Heesemann.   

Abstract

Cytokines are important mediators of the inflammatory host response against infectious agents. In this study, the role of tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) in the elimination of a primary infection with highly virulent Yersinia enterocolitica serotype 0:8 strain WA-P has been investigated in C57BL/6 mice. The injection of anti-TNF-alpha or anti-IFN-gamma antibodies ("serotherapy") prior to the intravenous challenge of a sublethal dose of Y. enterocolitica caused an increased bacterial net-growth in the spleens, although this effect was more pronounced for anti-TNF-alpha treatment. The later treatment with anti-TNF-alpha or anti-IFN-gamma antibodies on day 3 post infection likewise abrogated resistance to Y. enterocolitica and, subsequently, led to death from progressive infection. Our data demonstrate for the first time that the endogenous production of both the cytokines TNF-alpha and IFN-gamma is required for the restriction of a primary Y. enterocolitica infection in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287419     DOI: 10.1007/bf00191545

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  25 in total

1.  Endogenous gamma interferon-independent host resistance against Listeria monocytogenes infection in CD4+ T cell- and asialo GM1+ cell-depleted mice.

Authors:  A Nakane; A Numata; Y Chen; T Minagawa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

2.  Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.

Authors:  T P Leist; M Eppler; R M Zinkernagel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies.

Authors:  P Mastroeni; A Arena; G B Costa; M C Liberto; L Bonina; C E Hormaeche
Journal:  Microb Pathog       Date:  1991-07       Impact factor: 3.738

5.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Modulation of Mycobacterium lepraemurium growth in murine macrophages: beneficial effect of tumor necrosis factor alpha and granulocyte-macrophage colony-stimulating factor.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.

Authors:  C M Theodos; L Povinelli; R Molina; B Sherry; R G Titus
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid.

Authors:  M Simonet; S Richard; P Berche
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

9.  Production of tumor necrosis factor during murine listeriosis.

Authors:  E A Havell
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  44 in total

1.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

2.  The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17.

Authors:  Joshua K Turner; Milton M McAllister; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

Review 3.  YopJ Family Effectors Promote Bacterial Infection through a Unique Acetyltransferase Activity.

Authors:  Ka-Wai Ma; Wenbo Ma
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

4.  Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.

Authors:  E Bohn; E Schmitt; C Bielfeldt; A Noll; R Schulte; I B Autenrieth
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.

Authors:  Wenpeng Gu; Xin Wang; Haiyan Qiu; Buyun Cui; Shiwen Zhao; Han Zheng; Yuchun Xiao; Junrong Liang; Ran Duan; Huaiqi Jing
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.

Authors:  I B Autenrieth; M Beer; E Bohn; S H Kaufmann; J Heesemann
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection.

Authors:  J C Pepe; M R Wachtel; E Wagar; V L Miller
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice.

Authors:  Scott A Handley; Peter H Dube; Paula A Revell; Virginia L Miller
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 9.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.